Minda Corporation files insolvency of its German subsidiary
Minda Corporation files insolvency of its German subsidiary

Minda Corporation files insolvency of its German subsidiary

Amir Shaikh Article rating: 4.2

In a meeting held on June 09, 2020, the board of directors of Minda Corporation Limited took the decision to file for insolvency of its German subsidiary, Minda KTSN Plastic Solutions GmbH & Co. KG (MKTSN)

World Bank envisages 3.2 per cent contraction in Indian economy
World Bank envisages 3.2 per cent contraction in Indian economy

World Bank envisages 3.2 per cent contraction in Indian economy

Amir Shaikh Article rating: 4.0

World Bank released its global economic outlook stating that the COVID-19 outbreak has put the global economy into severe contraction. It estimates the world economy to contract by almost about 5.2 per cent this year, demonstrating the deepest recession since World War II

AstraZeneca Pharma India hits all-time high
AstraZeneca Pharma India hits all-time high

AstraZeneca Pharma India hits all-time high

Amir Shaikh Article rating: 3.7

According to Bloomberg news, British pharma company AstraZeneca plc has advanced the proposition for a potential merger to an American biopharmaceutical company, Gilead Sciences Inc

How Nifty constituents performed in Q4FY20?
How Nifty constituents performed in Q4FY20?

How Nifty constituents performed in Q4FY20?

Amir Shaikh Article rating: 4.1

We bid goodbye to FY2019-20 during the COVID-19 induced 21-day first nationwide lockdown which started on March 25, halting the economic wheel. Yet, we are aware that such a situation was not only in India, but experienced worldwide due to Coronavirus outbreak.

Aurobindo Pharma's US facility gets nine observations from USFDA
Aurobindo Pharma's US facility gets nine observations from USFDA

Aurobindo Pharma's US facility gets nine observations from USFDA

Amir Shaikh Article rating: 4.0

Aurobindo Pharma announced today that its wholly-owned subsidiary AuroLife Pharma LLC's oral solid manufacturing facility located at Dayton, New Jersey was inspected by United States Food and Drug Administration (USFDA) and thereafter, issued a Form 483 with nine observations

Strides Pharma receives USFDA approval for ointment, treating dermatoses
Strides Pharma receives USFDA approval for ointment, treating dermatoses

Strides Pharma receives USFDA approval for ointment, treating dermatoses

Amir Shaikh Article rating: 4.3

Strides Pharma Science announced today that its wholly owned subsidiary in Singapore, Strides Pharma Global Pte. Limited (SPG), has received USFDA approval for Triamcinolone Acetonide Ointment USP, 0.05 per cent

Biocon rallies as PTAB rules in its favour
Biocon rallies as PTAB rules in its favour

Biocon rallies as PTAB rules in its favour

Amir Shaikh Article rating: 4.5

Biocon made an announcement that U.S. Patent and Trademark Appeal Board (PTAB) has administered in favour of Biocon's partner, Mylan, in inter partes review (IPR) proceedings, regarding all challenged claims of Sanofi's Lantus SoloSTAR device patents

Aster DM Healthcare suspends capex plans amid COVID-19 situation
Aster DM Healthcare suspends capex plans amid COVID-19 situation

Aster DM Healthcare suspends capex plans amid COVID-19 situation

Amir Shaikh Article rating: 4.0

Health care provider, Aster DM Healthcare made an announcement today about the impact the outbreak of COVID-19 has had on its business. It stated that its regular business operations were substantially impacted due to the nationwide lockdown situation

Dilip Buildcon brings in Rs 100 crore via NCDs
Dilip Buildcon brings in Rs 100 crore via NCDs

Dilip Buildcon brings in Rs 100 crore via NCDs

Amir Shaikh Article rating: 4.0

Dilip Buildcon declared today that it has raised Rs 100 crore by the issue of rated, listed, redeemable, senior, secured non-convertible debentures (NCDs)

India lifts ban on export of paracetamol API
India lifts ban on export of paracetamol API

India lifts ban on export of paracetamol API

Amir Shaikh Article rating: 4.2

On Thursday, Directorate General of Foreign Trade (DGFT) declared in a statement that the Government of India has now lifted the restriction on active pharmaceutical ingredient (API) exports of paracetamol with immediate effect

RSS
First34568101112Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR